Last updated: 2026-09-04 21:31:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Elevance Health, Inc. (ELV) operates in the HOSPITAL & MEDICAL SERVICE PLANS sector and is listed on NYSE. The stock is currently priced at $407.43, with a market capitalisation of $88.01B and a P/E ratio of 18.12. Over the past 52 weeks, its price has ranged from $274.84 to $436.24. This page covers its latest market performance, valuation, price trends and company information.
$88.01B | |
$413.68 | |
$567.26 | |
$0.14 | |
$414.78 | |
702.78K | |
-- | |
18.12 | |
$436.24 | |
$274.84 | |
1.68% | |
-- |
Elevance Health, Inc. (ELV) is trading at $407.45 in after-hours trading as of 2026-09-04 21:18:00, down 1.77% ($7.33) from the regular-session close of $414.78.
After-hours trading shows how investors are pricing ELV after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Elevance Health, Inc. (ELV) moved from $393.94 to $407.43, representing a gain of 3.42% ($13.49).
The stock traded between $406.41 and $414.10 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 938.88 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 82.1%
ELV is currently trading at $407.43, placing it 82.1% of the way from its 52-week low of $274.84 to its 52-week high of $436.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
| Industry | HOSPITAL & MEDICAL SERVICE PLANS |
| Employees | 97100 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Elevance Health, Inc. (ELV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.